QGEN announces the launch of FDA-cleared QIAstat-Dx Rise, which may boost U.S. diagnostic access and testing capacity worldwide.

EQR reaffirms 2025 revenue and occupancy guidance, driven by strong leasing season trends and resilient renter demand.

Elliott Management's recent $4 billion stake in PepsiCo signals a strong conviction that the beverage-and-snacks leader can unlock more value. Elliott argues the company would benefit from a sharper strategic reset, highlighting meaningful upside from operational upgrades, cost discipline, and portfolio re-shaping.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Pfizer on Wednesday defended the effectiveness of its COVID-19 vaccine, saying it has saved more than 14 million lives worldwide, after U.S. President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs.

J.Jill, Inc. (NYSE:JILL ) Q2 2025 Earnings Call September 3, 2025 8:00 AM EDT Company Participants Mary Coyne - CEO, President & Director Mark Webb - Executive VP and Chief Financial & Operating Officer Conference Call Participants Jungwon Kim - TD Cowen, Research Division Corey Tarlowe - Jefferies LLC, Research Division Janine Hoffman Stichter - BTIG, LLC, Research Division Marni Shapiro - The Retail Tracker Presentation Operator Thank you for standing by, and welcome to the J.Jill Second Quarter 2025 Earnings Conference Call. Before we begin, I need to remind you that certain comments made during these remarks may constitute …

Zscaler's NASDAQ: ZS share price can hit a fresh high before year-end because the FQ4 results were better than expected, affirming its robust growth outlook.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient's own platelets and plasma that, once applied, may assist the natural healing process by maintaining a moist wound environment.

Ralph Lauren (RL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Dillard's (DDS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Casey's (CASY) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Halozyme Therapeutics (HALO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The growing adoption of AFRM's BNPL offerings across different merchants, consumers, & funding partners have triggered a consistently improving operating scale. The same has been observed in the fintech's robust top/ bottom-line performances in FQ4'25 and the management's promising FY2026 guidance. Much of the tailwinds are naturally attributed to the promising cross selling trends from its basic BNPL offerings to Affirm Card and 0% APR monthly promo.

CINCINNATI , Sept. 3, 2025 /PRNewswire/ -- The E.W.

United Therapeutics' stock (NASDAQ: UTHR) surged 33% on September 2nd after the company announced positive late-stage clinical trial results for Tyvaso (treprostinil) Inhalation Solution in idiopathic pulmonary fibrosis (IPF). The trial met its primary endpoint, and the treatment showed good tolerability with a safety profile consistent with prior Tyvaso studies.

The Marshalls Good Stuff Accelerator Program is a year-long virtual experience offering women practical tools, resources, and community to help make meaningful progress toward professional or personal goals FRAMINGHAM, Mass. , Sept. 3, 2025 /PRNewswire/ -- Marshalls (NYSE: TJX) is launching year two of The Marshalls Good Stuff Accelerator Program: a year-long, fully virtual experience that gives women more of the resources they need to unlock the good stuff in their lives – from personal growth to professional achievement.

RomanR / Shutterstock.com For one, gold is pushing higher after a U.S.

SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”). The lawsuit seeks to recover losses on behalf of investors who acquired their stock pursuant to the October 2024 initial public offering (“IPO”).